Evaluation of transporter-mediated hepatobiliary transport of newly developed 18F-labeled pitavastatin derivative, PTV-F1, in rats by PET imaging-Reference-Cited by-同舟云学术

Evaluation of transporter-mediated hepatobiliary transport of newly developed 18F-labeled pitavastatin derivative, PTV-F1, in rats by PET imaging

Published:2019-10 Issue:5 Volume:34 Page:317-324
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Kimura Hiroyuki,Yagi Yusuke,Mikamo Mutsumi,Maeda Kazuya,Kagawa Shinya,Arimitsu Kenji,Higashi Tatsuya,Nishii Ryuichi,Ono Masahiro,Nakamoto Yuji,Togashi Kaori,Kusuhara Hiroyuki,Saji Hideo

Funder

National Institute of Biomedical Innovation

Japan Society for the Promotion of Science

Takeda Science Foundation

Ministry of Health, Labor and Welfare of Japan

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference19 articles.

1. Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms;Yoshida;Annu Rev Pharmacol Toxicol,2013

2. International transporter C. Transporters in drug development: 2018 ITC recommendations for transporters of emerging clinical importance;Zamek-Gliszczynski;Clin Pharmacol Ther,2018

3. PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me;Takashima;J Nucl Med,2012

4. Positron emission tomography studies using (15R)-16-m-[11C]tolyl-17,18,19,20-tetranorisocarbacyclin methyl ester for the evaluation of hepatobiliary transport;Takashima;J Pharmacol Exp Ther,2010

5. Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats;Shingaki;J Pharmacol Exp Ther,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress in in vivo phenotyping technologies for better prediction of transporter-mediated drug–drug interactions;Drug Metabolism and Pharmacokinetics;2020-02

2. Use of imaging to assess the activity of hepatic transporters;Expert Opinion on Drug Metabolism & Toxicology;2020-01-23